RE:RE:RE:RE:RE:RE:RE:Excellent Thanks JFM, always enjoy the insight.
I think many on this board including SPCEO are confusing TH for Berkshire Hatahway or some other massive conglomerate with significant earnings. When you are Biotech, you get diluted. Why is that so hard to swallow? The only thing that comes to mind is most don't have the funds to increase their position by 32% today. Last week they praise the company for rolling out 2 FDA approved programs and increasing sales and today they forgot that and don't want to increase their holdings by 32%, but rather sell. Seems backwards to me. I get it, dilution sucks, but welcome to Biotech.., how that's surprising to so many posters here is shocking to me. Maybe you didn't know wha let you were buying and that is compounded by the lack of trust you have with management. Whatever it's is, TH isn't going anywhere. If you complain the stock could have hit $40 and now will only make it to $28, tough luck! We are also not going repeat 2012. Smart Money buys on events like this.